NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.11012
+0.0101 (10.12%)
Oct 30, 2026, 3:54 PM EDT
NDT Pharmaceuticals Market Cap
NDT Pharmaceuticals has a market cap or net worth of $21.04 million as of October 30, 2026. It is the 36,406th most valuable company in the world and the 5,160th biggest in the United States. Its market cap has decreased by 85.84% in one year.
Market Cap
21.04M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#5,160 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 21, 2011, NDT Pharmaceuticals's market cap has increased from 2.76M to 21.04M, an increase of 662.52%. That is a compound annual growth rate of 14.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 21.04M | -92.02% |
| Dec 31, 2025 | 263.50M | 3,007.18% |
| Dec 31, 2024 | 8.48M | -13.47% |
| Dec 28, 2023 | 9.80M | 1,785.32% |
| Dec 31, 2021 | 519.82K | -69.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arch Biopartners | 39.37M |
| Cell Source | 36.49M |
| ZIVO Bioscience | 33.71M |
| Provectus Biopharmaceuticals | 20.93M |
| Biomind Labs | 19.41M |
| Hepion Pharmaceuticals | 17.68M |
| Inhibitor Therapeutics | 16.82M |
| Vicapsys Life Sciences | 14.57M |